HRP Anti-Cytokeratin 13 antibody [EPR3671]
- BOND RX™ Validated
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(1 Publication)
Rabbit Recombinant Monoclonal Cytokeratin 13 antibody - conjugated to HRP. Suitable for IHC-P, WB and reacts with Human samples. Cited in 1 publication.
View Alternative Names
Cytokeratin-13, Keratin-13, CK-13, K13, KRT13
- IHC-P
Lab
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - HRP Anti-Cytokeratin 13 antibody [EPR3671] (AB199092)
IHC image of Cytokeratin 13 staining in a section of formalin-fixed paraffin-embedded normal human tonsil tissue*, performed on a Leica BONDTM. The section was pre-treated using heat mediated antigen retrieval with sodium citrate buffer (pH6, epitope retrieval solution 1) for 20mins. The section was then incubated with ab199092, 1/100 dilution, for 15 mins at room temperature. DAB was used as the chromogen. The section was then counterstained with haematoxylin and mounted with DPX. The inset negative control image is taken from an identical assay without primary antibody.
For other IHC staining systems (automated and non-automated) customers should optimize variable parameters such as antigen retrieval conditions, primary antibody concentration and antibody incubation times.
*Tissue obtained from the Human Research Tissue Bank, supported by the NIHR Cambridge Biomedical Research Centre
- WB
Lab
Western blot - HRP Anti-Cytokeratin 13 antibody [EPR3671] (AB199092)
This blot was produced using a 4-12% Bis-tris gel under the MOPS buffer system. The gel was run at 200V for 50 minutes before being transferred onto a Nitrocellulose membrane at 30V for 70 minutes. The membrane was then blocked for an hour using 2% Bovine Serum Albumin before being incubated with ab199092 overnight at 4°C. Antibody binding was visualised using ECL development solution ab133406.
All lanes:
Western blot - HRP Anti-Cytokeratin 13 antibody [EPR3671] (ab199092) at 1/5000 dilution
All lanes:
A431 (Human epithelial carcinoma cell line) Whole Cell Lysate at 10 µg
Predicted band size: 50 kDa
Observed band size: 50 kDa
true
Exposure time: 10s
Related conjugates and formulations (9)
-
519 Alexa Fluor® 488
Alexa Fluor® 488 Anti-Cytokeratin 13 antibody [EPR3671]
-
665 Alexa Fluor® 647
Alexa Fluor® 647 Anti-Cytokeratin 13 antibody [EPR3671]
-
660 APC
APC Anti-Cytokeratin 13 antibody [EPR3671]
-
578 PE
PE Anti-Cytokeratin 13 antibody [EPR3671]
-
617 Alexa Fluor® 594
Alexa Fluor® 594 Anti-Cytokeratin 13 antibody [EPR3671]
-
565 Alexa Fluor® 555
Alexa Fluor® 555 Anti-Cytokeratin 13 antibody [EPR3671]
-
775 Alexa Fluor® 750
Alexa Fluor® 750 Anti-Cytokeratin 13 antibody [EPR3671]
-
Anti-Cytokeratin 13 antibody [EPR3671]
-
Anti-Cytokeratin 13 antibody [EPR3671] - BSA and Azide free
Reactivity data
Product details
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This protein participates in maintaining the structural framework and dynamics within epithelial tissues. As part of the cytoskeletal complex cytokeratin 13 supports cellular resilience against mechanical stress. It interacts with other cytokeratins contributing to the formation of a robust keratin filament network essential for epithelial cell function and differentiation. Its expression and regulation are key to the homeostasis of the tissues where it is found ensuring proper cell division and tissue integrity.
Pathways
Cytokeratin 13 integrates into epithelial cell differentiation and repair processes. It is involved in the epithelial-mesenchymal transition (EMT) pathway important for tissue development wound healing and cancer metastasis. During the EMT process cytokeratin 13 often works alongside proteins like E-cadherin and Vimentin mediating changes in epithelial cell architecture and polarity. This modulation is essential for cellular plasticity and response to environmental cues.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (1)
Recent publications for all applications. Explore the full list and refine your search
The Journal of clinical investigation 135: PubMed40100289
2025
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com